|  | Group ED (n = 48) | Group NED (n = 465) | p -value |
---|---|---|---|---|
Sex | Male | 40 | 387 | Â |
 | Female | 8 | 78 | 0.9849 |
Age | <60 | 24 | 211 | Â |
 | 60 ≤ | 24 | 254 | 0.5405 |
HBV | + | 26 | 195 | Â |
 | - | 22 | 270 | 0.1033 |
HCV | + | 14 | 175 | Â |
 | - | 34 | 290 | 0.2469 |
Albumin | <4 | 33 | 214 | Â |
(g/dl) | 4 ≤ | 15 | 251 | 0.0027 |
Total bilirubin | <0.8 | 32 | 283 | Â |
(mg/dl) | 0.8 ≤ | 16 | 182 | 0.4314 |
ICGR15 (%) | <15 | 27 | 250 | Â |
 | 15 ≤ | 21 | 215 | 0.7421 |
Child-Pugh | A | 42 | 457 | Â |
 | B | 6 | 8 | <0.0001 |
AFP (ng/ml) | ≤200 | 15 | 355 |  |
 | 200<, ≤1,000 | 5 | 37 |  |
 | 1,000< | 28 | 73 | <0.0001 |
AFP-L3 (%) | ≤15 | 23 | 334 |  |
 | 15% < 40< | 5 | 49 |  |
 | 40< | 20 | 83 | 0.0002 |
PIVKA-II (mAU/ml) | ≤100 | 10 | 258 |  |
 | 100<, ≤1,000 | 8 | 93 |  |
 | 1,000< | 30 | 114 | <0.0001 |
Liver cirrhosis | Present | 17 | 158 | Â |
 | Absent | 31 | 307 | 0.8414 |
Curability | R0 R1 | 40 | 443 | Â |
 | R2 | 8 | 22 | 0.0008 |
Anatomical resection | Yes | 42 | 326 | Â |
 | No | 6 | 139 | 0.0108 |
Tumor number | 1 | 16 | 321 | Â |
 | 2, 3 | 11 | 113 |  |
 | 4 ≤ | 21 | 31 | <0.0001 |
Tumor size | ≤2 cm | 4 | 64 |  |
 | 2-5 cm | 6 | 254 |  |
 | 5 cm ≤ | 38 | 147 | <0.0001 |
Macroscopic vascular invasion | Absent | 28 | 440 | Â |
(portal vein, hepatic vein) | Present | 20 | 25 | <0.0001 |
Differentiation | Well | 0 | 50 | Â |
 | Moderate | 19 | 308 |  |
 | Poor | 29 | 92 |  |
 | Necrosis | 0 | 15 | <0.0001 |
Microscopic portal vein invasion | vp0 | 10 | 369 | Â |
 | vp1 | 13 | 60 |  |
 | vp2 | 7 | 15 |  |
 | vp3 | 12 | 15 |  |
 | vp4 | 6 | 6 | <0.0001 |
Microscopic hepatic vein invasion | vv0 | 28 | 439 | Â |
 | vv1 | 8 | 12 |  |
 | vv2 | 9 | 10 |  |
 | vv3 | 3 | 4 | <0.0001 |
Distant metastasis | Absent | 43 | 459 | Â |
 | Present | 5 | 6 | <0.0001 |